• 1  Darier J. De la psorospermose folliculaire vegetante. Ann Dermatol Syphilol 1889;10:597–612.
  • 2  White JC. A case of keratosis (ichthyosis) follicularis. J Cutan Dis 1889;7:201–9.
  • 3  Burge SM, Wilkinson JD. Darier–White disease: a review of the clinical features in 163 patients. J Am Acad Dermatol 1992;27:40–50. Cross Ref link Pubmed link
  • 4  Munro CS. The phenotype of Darier's disease: penetrance and expressivity in adults and children. Br J Dermatol 1992;127:126–30. Cross Ref link Pubmed link
  • 5  Burge S. Darier's disease – the clinical features and pathogenesis. Clin Exp Dermatol 1994;19:193–205. Cross Ref link Pubmed link
  • 6  Gordon‐Smith K, Jones LA, Burge SM, et al. The neuropsychiatric phenotype in Darier disease. Br J Dermatol 2010;163:515–22. Cross Ref link Pubmed link
  • 7  Svendsen I, Albrechtsen B. The prevalence of dyskeratosis follicularis (Darier's disease) in Denmark: an investigation of the heredity in 22 families. Acta Derm Venereol Stockh 1959;39:256–69. Pubmed link
  • 8  Wilkinson JD, Marsden R, Dawber RPR. Review of Darier's disease in the Oxford region. Br J Dermatol 1977;97(S15):15‐16. Cross Ref link
  • 9  Tavadia S, Mortimer E, Munro CS. Genetic epidemiology of Darier's disease: a population study in the west of Scotland. Br J Dermatol 2002;146:107–9. Cross Ref link Pubmed link
  • 10  Getzler NA, Flint A. Keratosis follicularis. A study of one family. Arch Dermatol 1966;93:545–9. Cross Ref link Pubmed link
  • 11  Herndon J, Wilson J. Acrokeratosis (Hopf) and Darier's disease. Arch Dermatol 1966;93:305–10. Cross Ref link
  • 12  Ellis R. Keratosis follicularis is not primarily a follicular disease. Arch Dermatol Syphilol 1944;50:27–30. Cross Ref link
  • 13  Gandarillas A, Goldsmith LA, Gschmeissner S, et al. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol 1999;8:71–9. Cross Ref link Pubmed link
  • 14  Gniadecki R, Jemec GB, Thomsen BM, et al. Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases. Arch Dermatol Res 1998;290:528–32. Cross Ref link Pubmed link
  • 15  Burge SM, Garrod DR. An immunohistological study of desmosomes in Darier's disease and Hailey–Hailey disease. Br J Dermatol 1991;124:242–51. Cross Ref link Pubmed link
  • 16  Hashimoto K, Fujiwara K, Tada J, et al. Desmosomal dissolution in Grover's disease, Hailey‐Hailey's disease and Darier's disease. J Cutan Pathol 1995;22:488–501. Cross Ref link Pubmed link
  • 17  Hakuno M, Shimizu H, Akiyama M, et al. Dissociation of intra‐ and extracellular domains of desmosomal cadherins and E‐cadherin in Hailey‐Hailey disease and Darier's disease. Br J Dermatol 2000;142:702–11. Cross Ref link Pubmed link
  • 18  Caulfield JB, Wilgram GF. An electron‐microscope study of dyskeratosis and acantholysis in Darier's disease. J Invest Dermatol 1963;41:57–65. Cross Ref link Pubmed link
  • 19  Carafoli E, Brini M. Calcium pumps: structural basis for and mechanism of calcium transmembrane transport. Curr Opin Chem Biol 2000;4:152–61. Cross Ref link Pubmed link
  • 20  Sakuntabhai A, Ruiz‐Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet 1999;21:271–7. Cross Ref link Pubmed link
  • 21  Sakuntabhai A, Burge S, Monk S, Hovnanian A. Spectrum of novel ATP2A2 mutations in patients with Darier's disease. Hum Mol Genet 1999;8:1611–19. Cross Ref link Pubmed link
  • 22  Ruiz‐Perez VL, Carter SA, Healy E, et al. ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class. Hum Mol Genet 1999;8:1621–30. Cross Ref link Pubmed link
  • 23  Jacobsen NJ, Lyons I, Hoogendoorn B, et al. ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes. Hum Mol Genet 1999;8:1631–6. Cross Ref link Pubmed link
  • 24  Ringpfeil F, Raus A, DiGiovanna JJ, et al. Darier disease – novel mutations in ATP2A2 and genotype–phenotype correlation. Exp Dermatol 2001;10:19–27. Cross Ref link Pubmed link
  • 25  Craddock N, Dawson E, Burge S, et al. The gene for Darier's disease maps to chromosome 12q23‐q24.1. Hum Mol Genet 1993;2:1941–3. Cross Ref link Pubmed link
  • 26  Carter SA, Bryce SD, Munro CS, et al. Linkage analyses in British pedigrees suggest a single locus for Darier disease and narrow the location to the interval between D12S105 and D12S129. Genomics 1994;24:378–82. Cross Ref link Pubmed link
  • 27  Brini M, Carafoli E. Calcium pumps in health and disease. Physiol Rev 2009;89:1341–78. Cross Ref link Pubmed link
  • 28  Hovnanian A. SERCA pumps and human diseases. Subcell Biochem 2007;45:337–63. Cross Ref link Pubmed link
  • 29  MacLennan DH. Ca2+ signalling and muscle disease. Eur J Biochem FEBS 2000;267(17):5291–7. Cross Ref link
  • 30  Kimura T, Nakamori M, Lueck JD, et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+‐ATPase in myotonic dystrophy type 1. Hum Mol Genet 2005;14(15):2189–200. Cross Ref link Pubmed link
  • 31  Tavadia S, Authi KS, Hodgins MB, et al. Expression of the sarco/endoplasmic reticulum calcium ATPase type 2 and 3 isoforms in normal skin and Darier's disease. Br J Dermatol 2004;151:440–5. Cross Ref link Pubmed link
  • 32  Foggia L, Hovnanian A. Calcium pump disorders of the skin. Am J Med Genet C Semin Med Genet 2004;131C:20–31. Cross Ref link Pubmed link
  • 33  Miyauchi Y, Daiho T, Yamasaki K, et al. Comprehensive analysis of expression and function of 51 sarco(endo)plasmic reticulum Ca2+‐ATPase mutants associated with Darier disease. J Biol Chem 2006;281(32):22882–95. Cross Ref link Pubmed link
  • 34  Dhitavat J, Dode L, Leslie N, et al. Mutations in the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase isoform cause Darier's disease. J Invest Dermatol 2003;121:486–9. Cross Ref link Pubmed link
  • 35  Ikeda S, Mayuzumi N, Shigihara T, et al. Mutations in ATP2A2 in patients with Darier's disease. J Invest Dermatol 2003;121:475–7. Cross Ref link Pubmed link
  • 36  Rácz E, Csikós M, Kornsée Z, et al. Identification of mutations in the ATP2A2 gene in patients with Darier's disease from Hungary. Exp Dermatol 2004;13:396–9. Cross Ref link Pubmed link
  • 37  Chao S‐C, Yang M‐H, Lee JY‐Y. Mutation analysis of the ATP2A2 gene in Taiwanese patients with Darier's disease. Br J Dermatol 2002;146:958–63. Cross Ref link Pubmed link
  • 38  Ren Y‐Q, Gao M, Liang Y‐H, et al. Five mutations of ATP2A2 gene in Chinese patients with Darier's disease and a literature review of 86 cases reported in China. Arch Dermatol Res 2006;298:58–63. Cross Ref link Pubmed link
  • 39  Bchetnia M, Charfeddine C, Kassar S, et al. Clinical and mutational heterogeneity of Darier disease in Tunisian families. Arch Dermatol 2009;145:654–6. Cross Ref link Pubmed link
  • 40  Pedace L, Barboni L, Pozzetto E, et al. Molecular characterization of 11 Italian patients with Darier disease. Eur J Dermatol 2011;21:334–8. Pubmed link
  • 41  Klausegger A, Nischler E, Wagner RN, et al. Seven novel mutations in the ATP2A2 gene of Austrian patients with Darier's disease. Arch Dermatol Res 2011;303:371–4. Cross Ref link Pubmed link
  • 42  Green EK, Gordon‐Smith K, Burge SM, et al. Novel ATP2A2 mutations in a large sample of individuals with Darier disease. J Dermatol 2013;40:259–66. Cross Ref link Pubmed link
  • 43  Ahn W, Lee MG, Kim KH, Muallem S. Multiple effects of SERCA2b mutations associated with Darier's disease. J Biol Chem 2003;278(23):20795–801. Cross Ref link Pubmed link
  • 44  Dode L, Andersen JP, Leslie N, et al. Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+‐ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady‐state and transient kinetic analyses. J Biol Chem 2003;278(48):47877–89. Cross Ref link Pubmed link
  • 45  Kaneko M, Desai BS, Cook B. Ionic leakage underlies a gain‐of‐function effect of dominant disease mutations affecting diverse P‐type ATPases. Nat Genet 2014;46:144–51. Cross Ref link Pubmed link
  • 46  Bikle DD, Xie Z, Tu C‐L. Calcium regulation of keratinocyte differentiation. Expert Rev Endocrinol Metab 2012;7:461–72. Cross Ref link Pubmed link
  • 47  Sato K, Yamasaki K, Daiho T, et al. Distinct types of abnormality in kinetic properties of three Darier disease‐causing sarco(endo)plasmic reticulum Ca2+‐ATPase mutants that exhibit normal expression and high Ca2+ transport activity. J Biol Chem 2004;279(34):35595–603. Cross Ref link Pubmed link
  • 48  Foggia L, Aronchik I, Aberg K, et al. Activity of the hSPCA1 Golgi Ca2+ pump is essential for Ca2+‐mediated Ca2 +response and cell viability in Darier disease. J Cell Sci 2006;119(4):671–9. Cross Ref link Pubmed link
  • 49  Leinonen PT, Hägg PM, Peltonen S, et al. Reevaluation of the normal epidermal calcium gradient, and analysis of calcium levels and ATP receptors in Hailey‐Hailey and Darier epidermis. J Invest Dermatol 2009;129:1379–87. Cross Ref link Pubmed link
  • 50  Kitajima Y. Mechanisms of desmosome assembly and disassembly. Clin Exp Dermatol 2002;27:684–90. Cross Ref link Pubmed link
  • 51  Pani B, Cornatzer E, Cornatzer W, et al. Up‐regulation of transient receptor potential canonical 1 (TRPC1) following sarco(endo)plasmic reticulum Ca2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier's disease. Mol Biol Cell 2006;17:4446–58. Cross Ref link Pubmed link
  • 52  Celli A, Mackenzie DS, Zhai Y, et al. SERCA2‐controlled Ca2+‐dependent keratinocyte adhesion and differentiation is mediated via the sphingolipid pathway: a therapeutic target for Darier's disease. J Invest Dermatol 2012;132:1188–95. Cross Ref link Pubmed link
  • 53  Michalak M, Robert Parker JM, Opas M. Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 2002;32(5–6):269–78. Cross Ref link Pubmed link
  • 54  Dhitavat J, Cobbold C, Leslie N, et al. Impaired trafficking of the desmoplakins in cultured Darier's disease keratinocytes. J Invest Dermatol 2003;121:1349–55. Cross Ref link Pubmed link
  • 55  Hobbs RP, Amargo EV, Somasundaram A, et al. The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKCα; signaling. FASEB J 2011;25:990–1001. Cross Ref link Pubmed link
  • 56  Wang Y, Bruce AT, Tu C, et al. Protein aggregation of SERCA2 mutants associated with Darier disease elicits ER stress and apoptosis in keratinocytes. J Cell Sci 2011;124(21):3568–80. Cross Ref link Pubmed link
  • 57  Bongiorno MR, Aricò M. The behaviour of Bcl‐2, Bax and Bcl‐x in Darier's disease. Br J Dermatol 2002;147:696–700. Cross Ref link Pubmed link
  • 58  Pasmatzi E, Badavanis G, Monastirli A, et al. Reduced expression of the antiapoptotic proteins of Bcl‐2 gene family in the lesional epidermis of patients with Darier's disease. J Cutan Pathol 2007;34:234–8. Cross Ref link Pubmed link
  • 59  Dremina ES, Sharov VS, Schöneich C. Heat‐shock proteins attenuate SERCA inactivation by the anti‐apoptotic protein Bcl‐2: possible implications for the ER Ca2+‐mediated apoptosis. Biochem J 2012;444:127–39. Cross Ref link Pubmed link
  • 60  Liu LH, Boivin GP, Prasad V, et al. Squamous cell tumors in mice heterozygous for a null allele of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+‐ATPase isoform 2 Ca2+ pump. J Biol Chem 2001;276(29):26737–40. Cross Ref link Pubmed link
  • 61  Prasad V, Boivin GP, Miller ML, et al. Haploinsufficiency of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+‐ATPase isoform 2 Ca2 +pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility. Cancer Res 2005;65(19):8655–61. Cross Ref link Pubmed link
  • 62  Shull GE, Miller ML, Prasad V. Secretory pathway stress responses as possible mechanisms of disease involving Golgi Ca2+ pump dysfunction. BioFactors Oxf Engl 2011;37:150–8. Cross Ref link
  • 63  Missiaen L, Dode L, Vanoevelen J, et al. Calcium in the Golgi apparatus. Cell Calcium 2007;41:405–16. Cross Ref link Pubmed link
  • 64  Müller EJ, Caldelari R, Kolly C, et al. Consequences of depleted SERCA2‐gated calcium stores in the skin. J Invest Dermatol 2006;126:721–31. Cross Ref link Pubmed link
  • 65  Fitzgerald DA, Lewis‐Jones MS. Darier's disease presenting as isolated hyperkeratosis of the breasts. Br J Dermatol 1997;136:290. Cross Ref link Pubmed link
  • 66  Rongioletti F, Cestari R, Rebora A. Verrucous and malodorous vegetations on the legs. Darier's disease, cornifying type. Arch Dermatol 1992;128:399, 402. Cross Ref link Pubmed link
  • 67  Zarour H, Grob JJ, Andrac L, et al. Palmoplantar orthokeratotic filiform hyperkeratosis in a patient with associated Darier's disease. Classification of filiform hyperkeratosis. Dermatol Basel Switz 1992;185:205–9. Cross Ref link
  • 68  Salmon‐Ehr V, Grosieux C, Derancourt C, et al. Palmoplantar filiform hyperkeratosis with Darier's disease. Association or coincidence? Eur J Dermatol 1998;8:519–20. Pubmed link
  • 69  Macleod RI, Munro CS. The incidence and distribution of oral lesions in patients with Darier's disease. Br Dent J 1991;171:133–6. Cross Ref link Pubmed link
  • 70  Larregue M, Katz M, Gasquet C, et al. [Esophageal localizations of Darier's disease. Radiological description apropos of >4 cases.] Med Cutánea Ibero‐Lat‐Am 1977;5:33–8.
  • 71  Vieites B, Seijo‐Ríos S, Suárez‐Peñaranda JM, et al. Darier's disease with esophageal involvement. Scand J Gastroenterol 2008;43:1020–1. Cross Ref link Pubmed link
  • 72  Ridley CM, Buckley CH. Darier's disease localized to the vulva. Br J Obstet Gynaecol 1991;98:112. Cross Ref link Pubmed link
  • 73  Salopek TG, Krol A, Jimbow K. Case report of Darier disease localized to the vulva in a 5‐year‐old girl. Pediatr Dermatol 1993;10:146–8. Cross Ref link Pubmed link
  • 74  Adam AE. Ectopic Darier's disease of the cervix: an extraordinary cause of an abnormal smear. Cytopathology 1996;7:414–21. Cross Ref link Pubmed link
  • 75  Al Robaee A, Hamadah IR, Khuroo S, et al. Extensive Darier's disease with esophageal involvement. Int J Dermatol 2004;43:835–9. Cross Ref link Pubmed link
  • 76  Suárez‐Peñaranda JM, Antúnez, Del Rio E, et al. Vaginal involvement in a woman with Darier's disease: a case report. Acta Cytol 2005;49:530–2. Cross Ref link Pubmed link
  • 77  Klein A, Burns L, Leyden JJ. Rectal mucosa involvement in keratosis follicularis. Arch Dermatol 1974;109:560–1. Cross Ref link Pubmed link
  • 78  Spouge JD, Trott, Chesko G. Darier‐White's disease: a cause of white lesions of the mucosa. Report of four cases. Oral Surg Oral Med Oral Pathol 1966;21:441–57. Cross Ref link Pubmed link
  • 79  Weathers DR, Driscoll RM. Darier's disease of the oral mucosa. Report of five cases. Oral Surg Oral Med Oral Pathol 1974;37:711–21. Cross Ref link Pubmed link
  • 80  Prindiville DE, Stern D. Oral manifestations of Darier's disease. J Oral Surg. 1976;34:1001–6. Pubmed link
  • 81  Ferris T, Lamey PJ, Rennie JS. Darier's disease: oral features and genetic aspects. Br Dent J 1990;168:71–3. Cross Ref link Pubmed link
  • 82  Frezzini C, Cedro M, Leao JC, et al. Darier disease affecting the gingival and oral mucosal surfaces. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:e29–33. Cross Ref link Pubmed link
  • 83  Graham‐Brown RA, Mann BS, Downton D, et al. Darier's disease with salivary gland obstruction. J R Soc Med 1983;76:609–11. Pubmed link
  • 84  Tegner E, Jonsson N. Darier's disease with involvement of both submandibular glands. Acta Derm Venereol 1990;70:451–2. Pubmed link
  • 85  Adams AM, Macleod RI, Munro CS. Symptomatic and asymptomatic salivary duct abnormalities in Darier's disease: a sialographic study. Dentomaxillofac Radiol 1994;23:25–8. Cross Ref link Pubmed link
  • 86  Daicker B. Ocular involvement in keratosis follicularis associated with retinitis pigmentosa. Clinicopathological case report. Int J Ophthalmol Z Für Augenheilkd 1995;209:47–51.
  • 87  Czyz C, Sharma P, Grossniklaus HE, et al. Clinical and pathologic eyelid alterations in a patient with Darier disease. Ophthal Plast Reconstr Surg 2011;27:e170–2. Cross Ref link Pubmed link
  • 88  Mielke J, Grüb M, Besch D, et al. Recurrent corneal ulcerations with perforation in keratosis follicularis (Darier‐White disease). Br J Ophthalmol 2002;86:1192–3. Cross Ref link Pubmed link
  • 89  Macsai MS, Agarwal S. Staphylococcal endophthalmitis following cataract extraction in a patient with Darier's disease. Cornea 1998;17:335–7. Cross Ref link Pubmed link
  • 90  Carlsson AM, Barrett GD. Postoperative endophthalmitis in a patient with Darier‐White disease. Can J Ophthalmol 2007;42:134–5. Pubmed link
  • 91  Blackman HJ, Rodrigues MM, Peck GL. Corneal epithelial lesions in keratosis follicularis (Darier's disease). Ophthalmology 1980;87:931–43. Cross Ref link Pubmed link
  • 92  Lagali N, Dellby A, Fagerholm P. In vivo confocal microscopy of the cornea in Darier‐White disease. Arch Ophthalmol 2009;127:816–18. Cross Ref link Pubmed link
  • 93  Harris A, Burge SM, Dykes PJ, et al. Handicap in Darier's disease and Hailey‐Hailey disease. Br J Dermatol 1996;135:959–63. Cross Ref link Pubmed link
  • 94  Dodiuk‐Gad R, Cohen‐Barak E, Ziv M, et al. Health‐related quality of life among Darier's disease patients. J Eur Acad Dermatol Venereol 2013;27:51–6. Cross Ref link Pubmed link
  • 95  Hori Y, Tsuru N, Niimura M. Bullous Darier's disease. Arch Dermatol 1982;118:278–9. Cross Ref link Pubmed link
  • 96  Reed WB. Bullous Darier's disease. Arch Dermatol 1969;100:508–9. Cross Ref link Pubmed link
  • 97  Colver GB, Gawkrodger DJ. Vesiculo‐bullous Darier's disease. Br J Dermatol 1992;126:416–17. Cross Ref link Pubmed link
  • 98  Telfer NR, Burge SM, Ryan TJ. Vesiculo‐bullous Darier's disease. Br J Dermatol 1990;122:831–4. Cross Ref link Pubmed link
  • 99  Brown VL, Kelly SE, Burge SM, et al. Extensive recalcitrant Darier disease successfully treated with laser ablation. Br J Dermatol 2010;162:227–9. Cross Ref link Pubmed link
  • 100  Mandel MA. Cornifying Darier's disease. Plast Reconstr Surg 1979;63:167–72. Cross Ref link Pubmed link
  • 101  Peck GL, Kraemer KH, Wetzel B, et al. Cornifying Darier disease – a unique variant. I. Report of a case. Arch Dermatol 1976;112:495–503. Cross Ref link Pubmed link
  • 102  Katta R, Reed J, Wolf JE. Cornifying Darier's disease. Int J Dermatol 2000;39:844–5. Cross Ref link Pubmed link
  • 103  Aliağaoğlu C, Atasoy M, Anadolu R, et al. Comedonal, cornifying and hypertrophic Darier's disease in the same patient: a Darier combination. J Dermatol 2006;33:477–80. Cross Ref link Pubmed link
  • 104  Derrick EK, Darley CR, Burge S. Comedonal Darier's disease. Br J Dermatol 1995;132:453–5. Cross Ref link Pubmed link
  • 105  Lee M‐W, Choi J‐H, Sung K‐J, et al. Two cases of comedonal Darier's disease. Clin Exp Dermatol 2002;27:714–15. Cross Ref link Pubmed link
  • 106  Tsuruta D, Akiyama M, Ishida‐Yamamoto A, et al. Three‐base deletion mutation c.120_122delGTT in ATP2A2 leads to the unique phenotype of comedonal Darier disease. Br J Dermatol 2010;162:687–9. Cross Ref link Pubmed link
  • 107  Chung J, Kim JY, Gye J, et al. A case of familial comedonal Darier's disease. Ann Dermatol 2011;23(Suppl. 3):S398–401. Cross Ref link Pubmed link
  • 108  Jones WN, Nix TE, Clark WH. Hemorrhagic Darier's disease. Arch Dermatol 1964;89:523–7. Cross Ref link Pubmed link
  • 109  Foresman PL, Goldsmith LA, Ginn L, et al. Hemorrhagic Darier's disease. Arch Dermatol 1993;129:511–12. Cross Ref link Pubmed link
  • 110  Coulson IH, Misch KJ. Haemorrhagic Darier's disease. J R Soc Med 1989;82:365–6. Pubmed link
  • 111  Regazzini R, Zambruno G, DeFilippi C, et al. Isolated acral Darier's disease with haemorrhagic lesions in a kindred. Br J Dermatol 1996;135:495–6. Cross Ref link Pubmed link
  • 112  Sánchez‐Salas MP, Latasa de Aranibar FJG, Oncíns Torres R, et al. Bullous‐hemorrhagic Darier disease. Skinmed 2011;9:65–6. Pubmed link
  • 113  Hamada T, Yasumoto S, Karashima T, et al. Recurrent p.N767S mutation in the ATP2A2 gene in a Japanese family with haemorrhagic Darier disease clinically mimicking epidermolysis bullosa simplex with mottled pigmentation. Br J Dermatol 2007;157:605–8. Cross Ref link Pubmed link
  • 114  Millard TP, Dhitavat J, Hollowood K, et al. “Groveroid” Darier's disease? Br J Dermatol 2004;150:600–2. Cross Ref link Pubmed link
  • 115  Cornelison RL, Smith EB, Knox JM. Guttate leukoderma in Darier's disease. Arch Dermatol 1970;102:447–50. Cross Ref link Pubmed link
  • 116  Jacyk WK, Visser AJ. Leukodermic macules in keratosis follicularis (Darier's disease). Int J Dermatol 1992;31:715–17. Cross Ref link Pubmed link
  • 117  Goh BK, Kumarasinghe SPW, Ng SK. Two Singaporean cases of guttate leucoderma in Darier's disease. Clin Exp Dermatol 2004;29:313–14. Cross Ref link Pubmed link
  • 118  Ohtake N, Takano R, Saitoh A, et al. Brown papules and leukoderma in Darier's disease: clinical and histological features. Dermatology 1994;188:157–9. Cross Ref link Pubmed link
  • 119  Rowley MJ, Nesbitt LT, Carrington PR, et al. Hypopigmented macules in acantholytic disorders. Int J Dermatol 1995;34:390–2. Cross Ref link Pubmed link
  • 120  Burge SM. Hailey‐Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 1992;126:275–82. Cross Ref link Pubmed link
  • 121  Dhitavat J, Macfarlane S, Dode L, et al. Acrokeratosis verruciformis of Hopf is caused by mutation in ATP2A2: evidence that it is allelic to Darier's disease. J Invest Dermatol 2003;120:229–32. Cross Ref link Pubmed link
  • 122  Cooper PH. Acantholytic dermatosis localized to the vulvocrural area. J Cutan Pathol 1989;16:81–4. Cross Ref link Pubmed link
  • 123  Langenberg A, Berger TG, Cardelli M, et al. Genital benign chronic pemphigus (Hailey‐Hailey disease) presenting as condylomas. J Am Acad Dermatol 1992;26:951–5. Cross Ref link Pubmed link
  • 124  Grover RW. Transient acantholytic dermatosis. Arch Dermatol 1970;101:426–34. Cross Ref link Pubmed link
  • 125  Fernández‐Figueras M‐T, Puig L, Cannata P, et al. Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases. Am J Dermatopathol 2010;32:541–9. Cross Ref link Pubmed link
  • 126  Powell J, Sakuntabhai A, James M, et al. Grover's disease, despite histological similarity to Darier's disease, does not share an abnormality in the ATP2A2 gene. Br J Dermatol 2000;143:658. Cross Ref link Pubmed link
  • 127  Sprecher E, Indelman M, Khamaysi Z, et al. Galli‐Galli disease is an acantholytic variant of Dowling‐Degos disease. Br J Dermatol 2007;156:572–4. Cross Ref link Pubmed link
  • 128  Gilchrist H, Jackson S, Morse L, et al. Galli‐Galli disease: a case report with review of the literature. J Am Acad Dermatol 2008;58:299–302. Cross Ref link Pubmed link
  • 129  Hanneken S, Rütten A, Pasternack SM, et al. Systematic mutation screening of KRT5 supports the hypothesis that Galli‐Galli disease is a variant of Dowling‐Degos disease. Br J Dermatol 2010;163:197–200. Pubmed link
  • 130  Schmieder A, Pasternack SM, Krahl D, et al. Galli‐Galli disease is an acantholytic variant of Dowling‐Degos disease: additional genetic evidence in a German family. J Am Acad Dermatol 2012;66:e250–1. Cross Ref link Pubmed link
  • 131  Hopf G. Űber eine nicht beschriebene disseminierte Keratoses (acrokeratosis verruciformis). Dermatol Zeitschr 1931;60:227–50. Cross Ref link
  • 132  Niedelman ML. Acrokeratosis verruciformis (Hopf) report of 14 cases in one family in four generations, with a review of the literature. Arch Dermatol Syphilol 1947;56:48–63. Cross Ref link
  • 133  Panja RK. Acrokeratosis verruciformis: (Hopf) – a clinical entity? Br J Dermatol 1977;96:643–52. Cross Ref link Pubmed link
  • 134  Dereure O. [Hopf's verruciform acrokeratosis and Darier's disease are related to mutations in the same gene, ATP2A2.] Ann Dermatol Vénéréol 2004;131(1 Pt 1):104. Cross Ref link Pubmed link
  • 135  Wang P‐G, Gao M, Lin G‐S, et al. Genetic heterogeneity in acrokeratosis verruciformis of Hopf. Clin Exp Dermatol 2006;31:558–63. Cross Ref link Pubmed link
  • 136  Berk DR, Taube JM, Bruckner AL, et al. A sporadic patient with acrokeratosis verruciformis of Hopf and a novel ATP2A2 mutation. Br J Dermatol 2010;163:653–4. Cross Ref link Pubmed link
  • 137  Bergman R, Sezin T, Indelman M, et al. Acrokeratosis verruciformis of Hopf showing P602L mutation in ATP2A2 and overlapping histopathological features with Darier disease. Am J Dermatopathol 2012;34:597–601. Cross Ref link Pubmed link
  • 138  Starink TM, Woerdeman MJ. Unilateral systematized keratosis follicularis. A variant of Darier's disease or an epidermal naevus (acantholytic dyskeratotic epidermal naevus)? Br J Dermatol 1981;105:207–14. Cross Ref link Pubmed link
  • 139  Munro CS, Cox NH. An acantholytic dyskeratotic epidermal naevus with other features of Darier's disease on the same side of the body. Br J Dermatol 1992;127:168–71. Cross Ref link Pubmed link
  • 140  Plantin P, Le Noac'h E, Leroy JP, et al. [Localized recurrent light‐induced Darier disease following Blaschko lines.] Ann Dermatol Vénéréol 1994;121:393–5. Pubmed link
  • 141  Gilaberte M, Puig L, Vidal D, et al. Acantholytic dyskeratotic naevi following Blaschko's lines: a mosaic form of Darier's disease. J Eur Acad Dermatol Venereol 2003;17:196–9. Cross Ref link Pubmed link
  • 142  Sakuntabhai A, Dhitavat J, Burge S, et al. Mosaicism for ATP2A2 mutations causes segmental Darier's disease. J Invest Dermatol 2000;115:1144–7. Cross Ref link Pubmed link
  • 143  Wada T, Shirakata Y, Takahashi H, et al. A Japanese case of segmental Darier's disease caused by mosaicism for the ATP2A2 mutation. Br J Dermatol 2003;149:185–8. Cross Ref link Pubmed link
  • 144  Harboe TL, Willems P, Jespersgaard C, et al. Mosaicism in segmental Darier disease: an in‐depth molecular analysis quantifying proportions of mutated alleles in various tissues. Dermatology 2011;222:292–6. Cross Ref link Pubmed link
  • 145  Harboe TL, Willems P, Jespersgaard C, Mølgaard Pousen ML, Sørensen FB, Bisgaard ML. Mosaicism in segmental Darier disease: an in‐depth molecular analysis quantifying proportions of mutated alleles in various tissues. Dermatology 2011;222:292–6. Cross Ref link Pubmed link
  • 146  Itin PH, Happle R. Darier disease with paired segmental manifestation of either excessive or absent involvement: a further step in the concept of twin spotting. Dermatology 2002;205:344–7. Cross Ref link Pubmed link
  • 147  Fölster‐Holst R, Nellen RGL, Jensen J‐M, et al. Molecular genetic support for the rule of dichotomy in type 2 segmental Darier disease. Br J Dermatol 2012;166:464–6. Cross Ref link Pubmed link
  • 148  Fong G, Capaldi L, Sweeney SM, et al. Congenital Darier disease. J Am Acad Dermatol 2008;59(2 Suppl. 1):S50–1. Cross Ref link Pubmed link
  • 149  Claudy AL, Gaudin OG, Granouillet R. Pox virus infection in Darier's disease. Clin Exp Dermatol 1982;7:261–5. Cross Ref link Pubmed link
  • 150  Doeglas HM, Moolhuysen TM. Kaposi's varicelliform eruption. Two cases caused by herpesvirus hominis infection complicating Darier's disease. Arch Dermatol 1969;100:592–5. Cross Ref link Pubmed link
  • 151  Parham DM, Gawkrodger DJ, Vestey JP, et al. Disseminated herpes simplex infection complicating Darier's disease: successful treatment with oral acyclovir. J Infect 1985;10:77–8. Cross Ref link Pubmed link
  • 152  Parslew R, Verbov JL. Kaposi's varicelliform eruption due to herpes simplex in Darier's disease. Clin Exp Dermatol 1994;19:428–9. Cross Ref link Pubmed link
  • 153  Nikkels AF, Beauthier F, Quatresooz P, et al. Fatal herpes simplex virus infection in Darier disease under corticotherapy. Eur J Dermatol 2005;15:293–7. Pubmed link
  • 154  Kandasamy R, Hecker M, Choi M, et al. Darier disease complicated by disseminated zoster. Dermatol Online J 2009;15:6. Pubmed link
  • 155  Haase O, Moser A, Rose C, et al. Generalized cowpox infection in a patient with Darier disease. Br J Dermatol 2011;164:1116–18. Cross Ref link Pubmed link
  • 156  Jegasothy BV, Humeniuk JM. Darier's disease: a partially immunodeficient state. J Invest Dermatol 1981;76:129–32. Cross Ref link Pubmed link
  • 157  Halevy S, Weltfriend S, Pick AI, et al. Immunologic studies in Darier's disease. Int J Dermatol 1988;27:101–5. Cross Ref link Pubmed link
  • 158  Soppi AM, Soppi E, Eskola J, et al. Cell‐mediated immunity in Darier's disease: effect of systemic retinoid therapy. Br J Dermatol 1982;106:141–52. Cross Ref link Pubmed link
  • 159  Patrizi A, Ricci G, Neri I, et al. Immunological parameters in Darier's disease. Dermatologica 1989;178:138–40. Cross Ref link Pubmed link
  • 160  Marks JG, Thor DE, Lowe RS. Darier's disease: an immunologic study. Arch Dermatol 1978;114:1336–9. Cross Ref link Pubmed link
  • 161  Latour DL, Amonette RA, Bale GF. Darier's disease associated with cutaneous malignancies. J Dermatol Surg Oncol 1981;7:408–12. Cross Ref link Pubmed link
  • 162  Orihuela E, Tyring SK, Pow‐Sang M, et al. Development of human papillomavirus type 16 associated squamous cell carcinoma of the scrotum in a patient with Darier's disease treated with systemic isotretinoin. J Urol 1995;153:1940–3. Cross Ref link Pubmed link
  • 163  Downs AM, Ward KA, Peachey RD. Subungual squamous cell carcinoma in Darier's disease. Clin Exp Dermatol 1997;22:277–9. Cross Ref link Pubmed link
  • 164  Vázquez J, Morales C, González LO, et al. Vulval squamous cell carcinoma arising in localized Darier's disease. Eur J Obstet Gynecol Reprod Biol 2002;102:206–8. Cross Ref link Pubmed link
  • 165  Alexandrescu DT, Dasanu CA, Farzanmehr H, et al. Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis? Br J Dermatol 2008;159:1378–80. Cross Ref link Pubmed link
  • 166  Matsui K, Makino T, Nakano H, et al. Squamous cell carcinoma arising from Darier's disease. Clin Exp Dermatol 2009;34:e1015–16. Cross Ref link Pubmed link
  • 167  Spizuoco A, Jain RD, Stockton T, et al. Mammary Paget disease in Darier disease: beware the wolf in sheep's clothing. Am J Dermatopathol 2012;34:449–51. Cross Ref link Pubmed link
  • 168  Crisp AJ, Payne CM, Adams J, et al. The prevalence of bone cysts in Darier's disease: a survey of 31 cases. Clin Exp Dermatol 1984;9:78–83. Cross Ref link Pubmed link
  • 169  Ramien ML, Prendiville JS, Brown KLB, et al. Cystic bone lesions in a boy with Darier disease: a magnetic resonance imaging assessment. J Am Acad Dermatol 2009;60:1062–6. Cross Ref link Pubmed link
  • 170  Castori M, Barboni L, Duncan PJ, et al. Darier disease, multiple bone cysts, and aniridia due to double de novo heterozygous mutations in ATP2A2 and PAX6. Am J Med Genet A 2009;149A:1768–72. Cross Ref link Pubmed link
  • 171  Tavadia S, Tait RC, McDonagh TA, et al. Platelet and cardiac function in Darier's disease. Clin Exp Dermatol 2001;26:696–9. Cross Ref link Pubmed link
  • 172  Mayosi BM, Kardos A, Davies CH, et al. Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure. Heart 2006;92:105–9. Cross Ref link Pubmed link
  • 173  Ehrt U, Brieger P. Comorbidity of keratosis follicularis (Darier's disease) and bipolar affective disorder: an indication for valproate instead of lithium. Gen Hosp Psychiatr 2000;22:128–9. Cross Ref link
  • 174  Dodiuk‐Gad R, Lerner M, Breznitz Z, et al. Learning disabilities in Darier's disease patients. J Eur Acad Dermatol Venereol 2014;28:314–19. Cross Ref link Pubmed link
  • 175  Craddock N, Owen M, Burge S, et al. Familial cosegregation of major affective disorder and Darier's disease (keratosis follicularis). J Ment Sci 1994;164:355–8.
  • 176  Ewald H, Mors O, Flint T, et al. Linkage analysis between manic depressive illness and the region on chromosome 12q involved in Darier's disease. Psychiatr Genet 1994;4:195–200. Cross Ref link Pubmed link
  • 177  Sidenberg DG, Berg D, Bassett AS, et al. Genetic linkage evaluation of twenty‐four loci in an eastern Canadian family segregating Darier's disease (keratosis follicularis). J Am Acad Dermatol 1994;31:27–30. Cross Ref link Pubmed link
  • 178  Jacobsen NJ, Franks EK, Elvidge G, et al. Exclusion of the Darier's disease gene, ATP2A2, as a common susceptibility gene for bipolar disorder. Mol Psychiatr 2001;6:92–7. Cross Ref link
  • 179  Jones I, Jacobsen N, Green EK, et al. Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease. Mol Psychiatr 2002;7:424–7. Cross Ref link
  • 180  Green EK, Grozeva D, Raybould R, et al. P2RX7: A bipolar and unipolar disorder candidate susceptibility gene? Am J Med Genet B Neuropsychiatr Genet 2009;150B:1063–9. Cross Ref link Pubmed link
  • 181  Clark RD, Hammer CJ, Patterson SD. A cutaneous disorder (Darier's disease) evidently exacerbated by lithium carbonate. Psychosomatics 1986;27:800–1. Cross Ref link Pubmed link
  • 182  Milton GP, Peck GL, Fu JJ, et al. Exacerbation of Darier's disease by lithium carbonate. J Am Acad Dermatol 1990;23(5 Pt 1):926–8. Cross Ref link Pubmed link
  • 183  Rubin MB. Lithium‐induced Darier's disease. J Am Acad Dermatol 1995;32:674–5. Cross Ref link Pubmed link
  • 184  Süle N, Tészás A, Kálmán E, et al. Lithium suppresses epidermal SERCA2 and PMR1 levels in the rat. Pathol Oncol Res 2006;12:234–6. Cross Ref link Pubmed link
  • 185  Cooper SM, Burge SM. Darier's disease: epidemiology, pathophysiology, and management. Am J Clin Dermatol 2003;4:97–105. Cross Ref link Pubmed link
  • 186  Burge S. Management of Darier's disease. Clin Exp Dermatol 1999;24:53–6. Cross Ref link Pubmed link
  • 187  Steijlen PM, Happle R, van Muijen GN, et al. Topical treatment with 13‐cis‐retinoic acid improves Darier's disease and induces the expression of a unique keratin pattern. Dermatologica 1991;182:178–83. Cross Ref link Pubmed link
  • 188  Burge SM, Buxton PK. Topical isotretinoin in Darier's disease. Br J Dermatol 1995;133:924–8. Cross Ref link Pubmed link
  • 189  English JC 3rd, Browne J, Halbach DP. Effective treatment of localized Darier's disease with adapalene 0.1% gel. Cutis 1999;63:227–30. Pubmed link
  • 190  Oster‐Schmidt C. The treatment of Darier's disease with topical tazarotene. Br J Dermatol 1999;141:603–4. Cross Ref link Pubmed link
  • 191  Cianchini G, Colonna L, Camaioni D, et al. Acral Darier's disease successfully treated with adapalene. Acta Derm Venereol 2001;81:57–8. Cross Ref link Pubmed link
  • 192  Abe M, Inoue C, Yokoyama Y, et al. Successful treatment of Darier's disease with adapalene gel. Pediatr Dermatol 2011;28:197–8. Cross Ref link Pubmed link
  • 193  Kragballe K, Steijlen PM, Ibsen HH, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double‐blind, vehicle‐controlled, right/left comparative study. Arch Dermatol 1995;131:556–60. Cross Ref link Pubmed link
  • 194  Rubegni P, Poggiali S, Sbano P, et al. A case of Darier's disease successfully treated with topical tacrolimus. J Eur Acad Dermatol Venereol 2006;20:84–7. Cross Ref link Pubmed link
  • 195  Lu Y, Zhang M‐H, Zhu W‐Y. A case of facial keratosis follicularis squamosa resembling atrophic acne scarring, successfully treated with topical pimecrolimus. Indian J Dermatol Venereol Leprol 2011;77:69–70. Cross Ref link Pubmed link
  • 196  Pérez‐Carmona L, Fleta‐Asín B, Moreno‐García‐Del‐Real C, et al. Successful treatment of Darier's disease with topical pimecrolimus. Eur J Dermatol 2011;21:301–2. Pubmed link
  • 197  Knulst AC, De La Faille HB, Van Vloten WA. Topical 5‐fluorouracil in the treatment of Darier's disease. Br J Dermatol 1995;133:463–6. Cross Ref link Pubmed link
  • 198  Velasco S, Guillet G. [Improvement of Darier's disease on treatment with topical >5‐fluorouracil.] Ann Dermatol Vénéréologie 2006;133:366–8. Cross Ref link
  • 199  Yoon TY, Kim JW, Kim MK. Successful treatment of Darier disease with topical 5‐fluorouracil. Br J Dermatol 2006;154:1210–12. Cross Ref link Pubmed link
  • 200  Schmidt H, Ochsendorf FR, Wolter M, et al. Topical 5‐fluorouracil in Darier disease. Br J Dermatol 2008;158:1393–6. Cross Ref link Pubmed link
  • 201  Le Bidre E, Delage M, Celerier P, et al. [Efficacy and risks of topical >5‐fluorouracil in Darier's disease.] Ann Dermatol Vénéréologie 2010;137(6–7):455–9. Cross Ref link
  • 202  Burge SM, Wilkinson JD, Miller AJ, et al. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease. Br J Dermatol 1981;104:675–9. Cross Ref link Pubmed link
  • 203  Dicken CH, Bauer EA, Hazen PG, et al. Isotretinoin treatment of Darier's disease. J Am Acad Dermatol 1982;6(4 Pt 2 Suppl.):721–6. Cross Ref link Pubmed link
  • 204  Vahlquist A, Lee JB, Michaëlsson G. Darier's disease and vitamin A. Concentrations of retinoids in serum and epidermis of untreated patients. Arch Dermatol 1982;118:389–92. Cross Ref link Pubmed link
  • 205  Christophersen J, Geiger JM, Danneskiold‐Samsoe P, et al. A double‐blind comparison of acitretin and etretinate in the treatment of Darier's disease. Acta Derm Venereol 1992;72:150–2. Pubmed link
  • 206  Ormerod AD, Campalani E, Goodfield MJD, et al. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol 2010;162:952–63. Cross Ref link Pubmed link
  • 207  Barnstedt SE. [Successful treatment of Darier disease with oral alitretinoin.] Hautarzt Z Für Dermatol Venerol Verwandte Geb 2012;63:139–41. Cross Ref link
  • 208  Letulé V, Herzinger T, Ruzicka T, et al. Treatment of Darier disease with oral alitretinoin. Clin Exp Dermatol 2013;38:523–5. Cross Ref link Pubmed link
  • 209  Zamiri M, Munro CS. Successful treatment with oral alitretinoin in women of childbearing potential with Darier's disease. Br J Dermatol 2013;169:709–10. Cross Ref link Pubmed link
  • 210  Larbre B, Nicolas JF, Frappaz A, et al. [Cyclosporine and Darier's disease.] Ann Dermatol Vénéréologie 1993;120:310–11.
  • 211  Shahidullah H, Humphreys F, Beveridge GW. Darier's disease: severe eczematization successfully treated with cyclosporin. Br J Dermatol 1994;131:713–16. Cross Ref link Pubmed link
  • 212  Martini P, Peonia G, Benedetti A, et al. Darier‐White syndrome and cyclosporin. Dermatol Basel Switz 1995;190:174–5. Cross Ref link
  • 213  Stewart LC, Yell J. Vulval Darier's disease treated successfully with ciclosporin. J Obstet Gynaecol 2008;28:108–9. Cross Ref link Pubmed link
  • 214  Exadaktylou D, Kurwa HA, Calonje E, et al. Treatment of Darier's disease with photodynamic therapy. Br J Dermatol 2003;149:606–10. Cross Ref link Pubmed link
  • 215  Avery HL, Hughes BR, Coley C, et al. Clinical improvement in Darier's disease with photodynamic therapy. Australas J Dermatol 2010;51:32–5. Cross Ref link Pubmed link
  • 216  Van't Westeinde SC, Sanders CJ, van Weelden H. Photodynamic therapy in a patient with Darier's disease. J Eur Acad Dermatol Venereol 2006;20:870–2. Pubmed link
  • 217  Dellon AL, Chretien PB, Peck GL. Successful treatment of Darier's disease by partial‐thickness removal of skin. Plast Reconstr Surg 1977;59:823–30. Cross Ref link Pubmed link
  • 218  Toombs EL, Peck GL. Electrosurgical treatment of etretinate‐resistant Darier's disease. J Dermatol Surg Oncol 1989;15:1277–80. Cross Ref link Pubmed link
  • 219  McElroy JA, Mehregan DA, Roenigk RK. Carbon dioxide laser vaporization of recalcitrant symptomatic plaques of Hailey‐Hailey disease and Darier's disease. J Am Acad Dermatol 1990;23(5 Pt 1):893–7. Cross Ref link Pubmed link
  • 220  Beier C, Kaufmann R. Efficacy of erbium:YAG laser ablation in Darier disease and Hailey‐Hailey disease. Arch Dermatol 1999;135:423–7. Cross Ref link Pubmed link
  • 221  Minsue Chen T, Wanitphakdeedecha R, Nguyen TH. Carbon dioxide laser ablation and adjunctive destruction for Darier‐White disease (keratosis follicularis). Dermatol Surg 2008;34:1431–4. Pubmed link
  • 222  Roos S, Karsai S, Ockenfel H‐M, et al. Successful treatment of Darier disease with the flashlamp‐pumped pulsed‐dye laser. Arch Dermatol 2008;144:1073–5. Cross Ref link Pubmed link
  • 223  Ahcan U, Dolenc‐Voljc M, Zivec K, et al. The surgical treatment of hypertrophic intertriginous Darier's disease. J Plast Reconstr Aesthetic Surg 2009;62:e442–6. Cross Ref link
  • 224  Kontochristopoulos G, Katsavou AN, Kalogirou O, et al. Botulinum toxin type A: an alternative symptomatic management of Darier's disease [Letter]. Dermatol Surg 2007;33:882–3. Pubmed link
  • 225  Santiago‐et‐Sánchez‐Mateos JL, Beà S, Fernández M, et al. Botulinum toxin type A for the preventive treatment of intertrigo in a patient with Darier's disease and inguinal hyperhidrosis. Dermatol Surg 2008;34:1733–7. Pubmed link
  • 226  Messikh R, Atallah L, Aubin F, et al. [Botulinum toxin in disabling dermatological diseases.] Ann Dermatol Vénéréologie 2009;136(Suppl. 4):S129–36. Cross Ref link
  • 227  Cohen PR. Darier disease: sustained improvement following reduction mammaplasty. Cutis 2003;72:124–6. Pubmed link
  • 228  Hailey H, Hailey H. Familial benign chronic pemphigus. Arch Dermatol Syphilol 1939;39:679–85. Cross Ref link
  • 229  Burge SM, Millard PR, Wojnarowska F. Hailey‐Hailey disease: a widespread abnormality of cell adhesion. Br J Dermatol 1991;124:329–32. Cross Ref link Pubmed link
  • 230  Metze D, Hamm H, Schorat A, Luger T. Involvement of the adherens junction‐actin filament system in acantholytic dyskeratosis of Hailey‐Hailey disease. A histological, ultrastructural, and histochemical study of lesional and non‐lesional skin. J Cutan Pathol 1996;23:211–22. Cross Ref link Pubmed link
  • 231  Hu Z, Bonifas JM, Beech J, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey‐Hailey disease. Nat Genet 2000;24:61–5. Cross Ref link Pubmed link
  • 232  Sudbrak R, Brown J, Dobson‐Stone C, et al. Hailey‐Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet 2000;9:1131–40. Cross Ref link Pubmed link
  • 233  Ikeda S, Shigihara T, Mayuzumi N, et al. Mutations of ATP2C1 in Japanese patients with Hailey‐Hailey disease: intrafamilial and interfamilial phenotype variations and lack of correlation with mutation patterns. J Invest Dermatol 2001;117:1654–6. Cross Ref link Pubmed link
  • 234  Dobson‐Stone C, Fairclough R, Dunne E, et al. Hailey‐Hailey disease: molecular and clinical characterization of novel mutations in the ATP2C1 gene. J Invest Dermatol 2002;118:338–43. Cross Ref link Pubmed link
  • 235  Fairclough RJ, Dode L, Vanoevelen J, et al. Effect of Hailey‐Hailey Disease mutations on the function of a new variant of human secretory pathway Ca2+/Mn2+‐ATPase (hSPCA1). J Biol Chem 2003;278(27):24721–30. Cross Ref link Pubmed link
  • 236  Fairclough RJ, Lonie L, Van Baelen K, et al. Hailey‐Hailey disease: identification of novel mutations in ATP2C1 and effect of missense mutation A528P on protein expression levels. J Invest Dermatol 2004;123:67–71. Cross Ref link Pubmed link
  • 237  Micaroni M, Perinetti G, Berrie CP, et al. The SPCA1 Ca2+ pump and intracellular membrane trafficking. Traffic 2010;11:1315–33. Cross Ref link Pubmed link
  • 238  Yoshida M, Yamasaki K, Daiho T, et al. ATP2C1 is specifically localized in the basal layer of normal epidermis and its depletion triggers keratinocyte differentiation. J Dermatol Sci 2006;43:21–33. Cross Ref link Pubmed link
  • 239  Behne MJ, Tu C‐L, Aronchik I, et al. Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2 +stores. J Invest Dermatol 2003;121:688–94. Cross Ref link Pubmed link
  • 240  Micaroni M, Mironov AA. Roles of Ca and secretory pathway Ca‐ATPase pump type 1 (SPCA1) in intra‐Golgi transport. Commun Integr Biol 2010;3:504–7. Cross Ref link Pubmed link
  • 241  Raiko L, Siljamäki E, Mahoney MG, et al. Hailey‐Hailey disease and tight junctions: Claudins 1 and 4 are regulated by ATP2C1 gene encoding Ca(2+) /Mn(2+) ATPase SPCA1 in cultured keratinocytes. Exp Dermatol 2012;21:586–91. Cross Ref link Pubmed link
  • 242  Ramos‐Castañeda J, Park Y, Liu M, et al. Deficiency of ATP2C1, a Golgi ion pump, induces secretory pathway defects in endoplasmic reticulum (ER)‐associated degradation and sensitivity to ER stress. J Biol Chem 2005;280:9467–73. Cross Ref link Pubmed link
  • 243  Aronchik I, Behne MJ, Leypoldt L, et al. Actin reorganization is abnormal and cellular ATP is decreased in Hailey‐Hailey keratinocytes. J Invest Dermatol 2003;121:681–7. Cross Ref link Pubmed link
  • 244  García‐Rodríguez N, Díaz de la Loza M del C, Andreson B, et al. Impaired manganese metabolism causes mitotic misregulation. J Biol Chem 2012;287(22):18717–29. Cross Ref link Pubmed link
  • 245  Okunade GW, Miller ML, Azhar M, et al. Loss of the Atp2c1 secretory pathway Ca(2+)‐ATPase (SPCA1) in mice causes Golgi stress, apoptosis, and midgestational death in homozygous embryos and squamous cell tumors in adult heterozygotes. J Biol Chem 2007;282(36):26517–27. Cross Ref link Pubmed link
  • 246  Dhitavat J, Fairclough RJ, Hovnanian A, et al. Calcium pumps and keratinocytes: lessons from Darier's disease and Hailey‐Hailey disease. Br J Dermatol 2004;150:821–8. Cross Ref link Pubmed link
  • 247  Szigeti R, Kellermayer R. Autosomal‐dominant calcium ATPase disorders. J Invest Dermatol 2006;126:2370–6. Cross Ref link Pubmed link
  • 248  Callewaert G, Parys JB, De Smedt H, et al. Similar Ca(2+)‐signaling properties in keratinocytes and in COS‐1 cells overexpressing the secretory‐pathway Ca(2+)‐ATPase SPCA1. Cell Calcium 2003;34:157–62. Cross Ref link Pubmed link
  • 249  Missiaen L, Raeymaekers L, Dode L, et al. SPCA1 pumps and Hailey‐Hailey disease. Biochem Biophys Res Commun 2004;322:1204–13. Cross Ref link Pubmed link
  • 250  Mayuzumi N, Ikeda S, Kawada H, et al. Effects of ultraviolet B irradiation, proinflammatory cytokines and raised extracellular calcium concentration on the expression of ATP2A2 and ATP2C1. Br J Dermatol 2005;152:697–701. Cross Ref link Pubmed link
  • 251  Mayuzumi N, Ikeda S, Kawada H, et al. Effects of drugs and anticytokine antibodies on expression of ATP2A2 and ATP2C1 in cultured normal human keratinocytes. Br J Dermatol 2005;152:920–4. Cross Ref link Pubmed link
  • 252  Marsch WC, Stüttgen G. Generalized Hailey‐Hailey disease. Br J Dermatol 1978;99:553–60. Cross Ref link Pubmed link
  • 253  Meffert JJ, Davis BM, Campbell JC. Bullous drug eruption to griseofulvin in a man with Hailey‐Hailey disease. Cutis 1995;56:279–80. Pubmed link
  • 254  Chave TA, Milligan A. Acute generalized Hailey‐Hailey disease. Clin Exp Dermatol 2002;27:290–2. Cross Ref link Pubmed link
  • 255  Galimberti RL, Kowalczuk AM, Bianchi O, et al. Chronic benign familial pemphigus. Int J Dermatol 1988;27:495–500. Cross Ref link Pubmed link
  • 256  Marren P, Burge S. Seborrhoeic dermatitis of the scalp – a manifestation of Hailey‐Hailey disease in a predisposed individual? Br J Dermatol 1992;126:294–6. Cross Ref link Pubmed link
  • 257  Richard G, Linse R, Harth W. [Hailey‐Hailey disease. Early detection of heterozygotes by an ultraviolet provocation tests – clinical relevance of the method.] Hautarzt Z Für Dermatol Venerol Verwandte Geb 1993;44:376–9.
  • 258  Pónyai G, Kárpáti S, Ablonczy E, et al. Benign familial chronic pemphigus (Hailey‐Hailey) provoked by contact sensitivity in 2 patients. Contact Dermatitis 1999;40:168–9. Cross Ref link Pubmed link
  • 259  Walker SL, Beck MH. Undiagnosed Hailey‐Hailey disease causing painful erosive skin changes during patch testing. Br J Dermatol 2005;153:233–4. Cross Ref link Pubmed link
  • 260  Podjasek JO, Cook‐Norris RH, Brewer JD. Painful erosions induced by patch testing in a patient with Hailey‐Hailey disease. Int J Dermatol 2013;52:123–4. Cross Ref link Pubmed link
  • 261  Morales A, Livingood CS, Hu F. Familial benign chronic pemphigus. Arch Dermatol 1966;93:324–8. Cross Ref link
  • 262  Kirtschig G, Effendy I, Happle R. [Leukonychia longitudinalis as the primary symptom of Hailey‐Hailey disease.] Hautarzt Z Für Dermatol Venerol Verwandte Geb 1992;43:451–2.
  • 263  Meawad OB, Assaf H. Longitudinal white streaks of fingernails: a useful clinical marker in genital verrucoid Hailey‐Hailey disease. J Eur Acad Dermatol Venereol. 5:177–80. Cross Ref link
  • 264  Kumar R, Zawar V. Longitudinal leukonychia in Hailey‐Hailey disease: a sign not to be missed. Dermatol Online J 2008;14:17.
  • 265  Bel B, Jeudy G, Vabres P. Dermoscopy of longitudinal leukonychia in Hailey‐Hailey disease. Arch Dermatol 2010;146:1204.
  • 266  Kostaki D, Castillo JC, Ruzicka T, et al. Longitudinal leuconychia striata: is it a common sign in Hailey‐Hailey and Darier disease? J Eur Acad Dermatol Venereol 2013;27(12):1586–7;
  • 267  Václavínková V, Neumann E. Vaginal involvement in familial benign chronic pemphigus (morbus Hailey‐Hailey). Acta Derm Venereol 1982;62:80–1.
  • 268  Fischer H, Nikolowski W. [The oral mucosa in benign familial chronic pemphigus.] Arch Für Klin Exp Dermatol 1962;214:261–73. Cross Ref link
  • 269  Oğuz O, Gökler G, Ocakoğlu O, et al. Conjunctival involvement in familial chronic benign pemphigus (Hailey‐Hailey disease). Int J Dermatol 1997;36:282–5.
  • 270  Heinze R. [Chronic benign familial pemphigus (Gougerot‐Hailey‐Hailey) with mucosal involvement in a diabetic.] Dermatol Monatschrift 1979;165:862–7.
  • 271  Kahn D, Hutchinson E. Esophageal involvement in familial benign chronic pemphigus. Arch Dermatol 1974;109:718–19. Cross Ref link Pubmed link
  • 272  Wong TY, Mihm MC. Acantholytic dermatosis localized to genitalia and crural areas of male patients: a report of three cases. J Cutan Pathol 1994;21:27–32. Cross Ref link Pubmed link
  • 273  Lipoff JB, Mudgil AV, Young S, et al. Acantholytic dermatosis of the crural folds with ATP2C1 mutation is a possible variant of Hailey‐Hailey Disease. J Cutan Med Surg 2009;13:151–4. Cross Ref link Pubmed link
  • 274  Pernet C, Bessis D, Savignac M, et al. Genitoperineal papular acantholytic dyskeratosis is allelic to Hailey‐Hailey disease. Br J Dermatol 2012;167:210–12. Cross Ref link Pubmed link
  • 275  Duschet P, Happle R, Schwarz T, et al. Relapsing linear acantholytic dermatosis. J Am Acad Dermatol 1995;33(5 Pt 2):920–2. Cross Ref link Pubmed link
  • 276  Vakilzadeh F, Kolde G. Relapsing linear acantholytic dermatosis. Br J Dermatol 1985;112:349–55. Cross Ref link Pubmed link
  • 277  Arora S, Arora G, Ranjan P. Relapsing linear acantholytic dermatosis in a four‐year‐old boy. Indian J Dermatol Venereol Leprol 2005;71:351–3. Cross Ref link Pubmed link
  • 278  Poblete‐Gutiérrez P, Wiederholt T, König A, et al. Allelic loss underlies type 2 segmental Hailey‐Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 2004;114:1467–74. Cross Ref link Pubmed link
  • 279  Mak RKH, Reynaert SMB, Agar N, et al. Hailey‐Hailey disease failing to respond to treatment. Clin Exp Dermatol 2005;30:598–9. Cross Ref link Pubmed link
  • 280  Colomb D, Vittori F, Latarche M. [Varioliform psutulosis of Kaposi and Juliusberg of herpetic origin, superinfected with a bullous genodermatosis in a >21‐year‐old girl: Hailey‐Hailey disease, transitional form with Darier's disease. Familial study and discussion.] Bull Société Française Dermatol Syphiligr 1971;78:278–81.
  • 281  Otsuka F, Niimura M, Harada S, et al. Generalized herpes simplex complicating Hailey‐Hailey's disease. J Dermatol 1981;8:63–8. Cross Ref link Pubmed link
  • 282  Zaim MT, Bickers DR. Herpes simplex associated with Hailey‐Hailey disease. J Am Acad Dermatol 1987;17:701–2. Cross Ref link Pubmed link
  • 283  Peppiatt T, Keefe M, White JE. Hailey‐Hailey disease – exacerbation by herpes simplex virus and patch tests. Clin Exp Dermatol 1992;17:201–2. Cross Ref link Pubmed link
  • 284  Lee GH, Kim YM, Lee SY, et al. A case of eczema herpeticum with Hailey‐Hailey disease. Ann Dermatol 2009;21:311–14. Cross Ref link Pubmed link
  • 285  Riahi RR, Yamazaki ML, Kelly BC. Tzanck smear utilized in the diagnosis of Hailey‐Hailey disease mimicking genital herpes. Int J Dermatol 2014;53:85–7. Cross Ref link Pubmed link
  • 286  Ewald K, Gross G. Perianal Hailey‐Hailey disease: an unusual differential diagnosis of condylomata acuminata. Int J STD AIDS 2008;19:791–2. Cross Ref link Pubmed link
  • 287  Evron S, Leviatan A, Okon E. Familial benign chronic pemphigus appearing as leukoplakia of the vulva. Int J Dermatol 1984;23:556–7. Cross Ref link Pubmed link
  • 288  Mashiko M, Akiyama M, Tsuji‐Abe Y, et al. Bacterial infection‐induced generalized Hailey‐Hailey disease successfully treated by etretinate. Clin Exp Dermatol 2006;31:57–9. Cross Ref link Pubmed link
  • 289  Chen M‐Y, Chiu H‐C, Su L‐H, et al. Presence of human papillomavirus type 6 DNA in the perineal verrucoid lesions of Hailey‐Hailey disease. J Eur Acad Dermatol Venereol 2006;20:1356–7. Cross Ref link Pubmed link
  • 290  Chan C‐C, Thong H‐Y, Chan Y‐C, et al. Human papillomavirus type 5 infection in a patient with Hailey‐Hailey disease successfully treated with imiquimod. Br J Dermatol 2007;156:579–81. Cross Ref link Pubmed link
  • 291  Chun SI, Whang KC, Su WP. Squamous cell carcinoma arising in Hailey‐Hailey disease. J Cutan Pathol 1988;15:234–7. Cross Ref link Pubmed link
  • 292  Holst VA, Fair KP, Wilson BB, et al. Squamous cell carcinoma arising in Hailey‐Hailey disease. J Am Acad Dermatol 2000;43(2 Pt 2):368–71. Cross Ref link Pubmed link
  • 293  Cockayne SE, Rassl DM, Thomas SE. Squamous cell carcinoma arising in Hailey‐Hailey disease of the vulva. Br J Dermatol 2000;142:540–2. Cross Ref link Pubmed link
  • 294  Ochiai T, Honda A, Morishima T, et al. Human papillomavirus types 16 and 39 in a vulval carcinoma occurring in a woman with Hailey‐Hailey disease. Br J Dermatol 1999;140:509–13. Cross Ref link Pubmed link
  • 295  Von Felbert V, Hampl M, Talhari C, et al. Squamous cell carcinoma arising from a localized vulval lesion of Hailey‐Hailey disease after tacrolimus therapy. Am J Obstet Gynecol 2010;203:e5–7. Cross Ref link Pubmed link
  • 296  Reitamo S, Remitz A, Lauerma AI, et al. Contact allergies in patients with familial benign chronic pemphigus (Hailey‐Hailey disease). J Am Acad Dermatol 1989;21(3 Pt 1):506–10. Cross Ref link Pubmed link
  • 297  Maniscalco M, Viviano E, Segreto A, et al. Malattia di Hailey‐Hailey. Spec Oggi‐Dermatol 1993;2:26–8.
  • 298  Körner J, Rietschel M, Nöthen MM, et al. Familial cosegregation of affective disorder and Hailey‐Hailey disease. Br J Psychiatry J Ment Sci 1993;163:109–10. Cross Ref link
  • 299  Wilk M, Rietschel M, Körner J, et al. [Pemphigus chronicus benignus familiaris (Hailey‐Hailey disease) and bipolar affective disease in >3 members of a family.] Hautarzt Z Für Dermatol Venerol Verwandte Geb 1994;45:313–17. Cross Ref link
  • 300  Yokota K, Sawamura D. Hailey‐Hailey disease with affective disorder: report of a case with novel ATP2C1 gene mutation. J Dermatol Sci 2006;43:150–1. Cross Ref link Pubmed link
  • 301  Leyden JJ, Marples RR. Superinfection induced by antibiotics in familial benign chronic pemphigus. Acta Derm Venereol 1973;53:61–4. Pubmed link
  • 302  Ikeda S, Suga Y, Ogawa H. Successful management of Hailey‐Hailey disease with potent topical steroid ointment. J Dermatol Sci 1993;5:205–11. Cross Ref link Pubmed link
  • 303  Umar SA, Bhattacharjee P, Brodell RT. Treatment of Hailey‐Hailey disease with tacrolimus ointment and clobetasol propionate foam. J Drugs Dermatol 2004;3:200–3. Pubmed link
  • 304  Rabeni EJ, Cunningham NM. Effective treatment of Hailey‐Hailey disease with topical tacrolimus. J Am Acad Dermatol 2002;47:797–8. Cross Ref link Pubmed link
  • 305  Sand C, Thomsen HK. Topical tacrolimus ointment is an effective therapy for Hailey‐Hailey disease. Arch Dermatol 2003;139:1401–2. Cross Ref link Pubmed link
  • 306  Rocha Paris F, Fidalgo A, Baptista J, et al. Topical tacrolimus in Hailey‐Hailey disease. Int J Tissue React 2005;27:151–4. Pubmed link
  • 307  Pagliarello C, Paradisi A, Dianzani C, et al. Topical tacrolimus and 50% zinc oxide paste for Hailey‐Hailey disease: less is more. Acta Derm Venereol 2012;92:437–8. Cross Ref link Pubmed link
  • 308  Laffitte E, Panizzon RG. Is topical tacrolimus really an effective therapy for Hailey‐Hailey disease? Arch Dermatol 2004;140:1282. Cross Ref link Pubmed link
  • 309  Aoki T, Hashimoto H, Koseki S, et al. 1‐alpha,24‐dihydroxyvitamin D3 (tacalcitol) is effective against Hailey‐Hailey disease both in vivo and in vitro. Br J Dermatol 1998;139:897–901. Cross Ref link Pubmed link
  • 310  Bianchi L, Chimenti MS, Giunta A. Treatment of Hailey‐Hailey disease with topical calcitriol. J Am Acad Dermatol 2004;51:475–6. Cross Ref link Pubmed link
  • 311  Rajpara SM, King CM. Hailey‐Hailey disease responsive to topical calcitriol. Br J Dermatol 2005;152:816–17. Cross Ref link Pubmed link
  • 312  Dammak A, Camus M, Anyfantakis V, et al. Successful treatment of Hailey‐Hailey disease with topical 5‐fluorouracil. Br J Dermatol 2009;161:967–8. Cross Ref link Pubmed link
  • 313  Kellermayer R, Szigeti R, Keeling KM, et al. Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey‐Hailey disease. J Invest Dermatol 2006;126:229–31. Cross Ref link Pubmed link
  • 314  Defresne C, Adam C, de Marneffe K. [Benign familial chronic pemphigus Hailey‐Hailey.] Dermatologica 1982;165:624–6. Cross Ref link Pubmed link
  • 315  Happle R, van de Kerkhof PC, Traupe H. Retinoids in disorders of keratinization: their use in adults. Dermatologica 1987;175(Suppl. 1):107–24. Cross Ref link Pubmed link
  • 316  Hunt MJ, Salisbury EL, Painter DM, et al. Vesiculobullous Hailey‐Hailey disease: successful treatment with oral retinoids. Australas J Dermatol 1996;37:196–8. Cross Ref link Pubmed link
  • 317  Berger EM, Galadari HI, Gottlieb AB. Successful treatment of Hailey‐Hailey disease with acitretin. J Drugs Dermatol 2007;6:734–6. Pubmed link
  • 318  Dajani ZAW, Mutasim DF. Ectopic facial Hailey‐Hailey disease. J Am Acad Dermatol 2011;65:223–4. Cross Ref link Pubmed link
  • 319  Sárdy M, Ruzicka T. Successful therapy of refractory Hailey‐Hailey disease with oral alitretinoin. Br J Dermatol 2014;170(1):209–11. Cross Ref link Pubmed link
  • 320  Jitsukawa K, Ring J, Weyer U, et al. Topical cyclosporine in chronic benign familial pemphigus (Hailey‐Hailey disease). J Am Acad Dermatol 1992;27:625–6. Cross Ref link Pubmed link
  • 321  Ormerod AD, Duncan J, Stankler L. Benign familial pemphigus responsive to cyclosporin, a possible role for cellular immunity in pathogenesis. Br J Dermatol 1991;124:299–300. Cross Ref link Pubmed link
  • 322  Berth‐Jones J, Smith SG, Graham‐Brown RA. Benign familial chronic pemphigus (Hailey‐Hailey disease) responds to cyclosporin. Clin Exp Dermatol 1995;20:70–2. Cross Ref link Pubmed link
  • 323  Nanda A, Khawaja F, Harbi R, et al. Benign familial pemphigus (Hailey‐Hailey disease) responsive to low dose cyclosporine. Indian J Dermatol Venereol Leprol 2010;76:422–4. Cross Ref link Pubmed link
  • 324  Cecchi R, Bartoli L, Brunetti L, et al. Pemfigo familiar benign (malattia di Hailey‐Hailey) trattato con ciclosporina A orale. G Ital Dermatol E Venereol 1993;128:615–17.
  • 325  Vilarinho C, Ventura F, Brito C. Methotrexate for refractory Hailey‐Hailey disease. J Eur Acad Dermatol Venereol 2010;24:106. Cross Ref link Pubmed link
  • 326  D'Errico A, Bonciani D, Bonciolini V, et al. Hailey‐Hailey disease treated with methotrexate. J Dermatol Case Rep 2012;6:49–51. Cross Ref link Pubmed link
  • 327  Sire DJ, Johnson BL. Benign familial chronic pemphigus treated with dapsone. Arch Dermatol 1971;103:262–5. Cross Ref link Pubmed link
  • 328  Johnson B. Benign familial chronic pemphigus treated with dapsone. J Natl Med Assoc 1972;64:326–7. Pubmed link
  • 329  Tomecki KJ. Hailey Hailey disease: clinical patterns and response to dapsone. Clin Res 1982;30:719A.
  • 330  Delfino M, Cinumino G, Maddaloni M, et al. Il pemfigo familiare benign di Hailey Hailey terapia con calcitriolo. Ann Ital Dermatol Clin Sper 1990;44:337–41.
  • 331  Le Saché‐de Peufeilhoux L, Raynaud E, Bouchardeau A, et al. Familial benign chronic pemphigus and doxycycline: a review of 6 cases. J Eur Acad Dermatol Venereol 2014;28(3):370–3. Cross Ref link Pubmed link
  • 332  Lew TT, Kaur MR, Hague JS. Oral terbinafine as an alternative treatment for Hailey‐Hailey disease. Clin Exp Dermatol 2013;38(8):929–30. Cross Ref link Pubmed link
  • 333  Norman R, Greenberg RG, Jackson JM. Case reports of etanercept in inflammatory dermatoses. J Am Acad Dermatol 2006;54(3 Suppl. 2):S139–42. Cross Ref link Pubmed link
  • 334  Hurd DS, Johnston C, Bevins A. A case report of Hailey‐Hailey disease treated with alefacept (Amevive). Br J Dermatol 2008;158:399–401. Pubmed link
  • 335  Kirtschig G, Gieler U, Happle R. Treatment of Hailey‐Hailey disease by dermabrasion. J Am Acad Dermatol 1993;28(5 Pt 1):784–6. Cross Ref link Pubmed link
  • 336  Hamm H, Metze D, Bröcker EB. Hailey‐Hailey disease. Eradication by dermabrasion. Arch Dermatol 1994;130:1143–9. Cross Ref link Pubmed link
  • 337  König A, Hörster S, Vakilzadeh F, et al. Type 2 segmental manifestation of Hailey‐Hailey disease: poor therapeutic response to dermabrasion is due to severe involvement of adnexal structures. Eur J Dermatol 2000;10:265–8. Pubmed link
  • 338  Konrad H, Karamfilov T, Wollina U. Intracutaneous botulinum toxin A versus ablative therapy of Hailey‐Hailey disease – a case report. J Cosmet Laser Ther 2001;3:181–4. Cross Ref link Pubmed link
  • 339  LeBlanc KG. Wharton JB, Sheehan DJ. Refractory Hailey‐Hailey disease successfully treated with sandpaper dermabrasion. Skinmed 2011;9:263–4. Pubmed link
  • 340  Quitadamo MJ, Spencer SK. Surgical management of Hailey‐Hailey disease. J Am Acad Dermatol 1991;25(2 Pt 1):342–3. Cross Ref link Pubmed link
  • 341  Kartamaa M, Reitamo S. Familial benign chronic pemphigus (Hailey‐Hailey disease). Treatment with carbon dioxide laser vaporization. Arch Dermatol 1992;128:646–8. Cross Ref link Pubmed link
  • 342  Christian MM, Moy RL. Treatment of Hailey‐Hailey disease (or benign familial pemphigus) using short pulsed and short dwell time carbon dioxide lasers. Dermatol Surg 1999;25:661–3. Cross Ref link Pubmed link
  • 343  Rivollier C, Martin L, Gironet N, et al. [Efficacy of CO2 laser in Hailey‐Hailey disease. A case report.] Ann Chir Plast Esthétique 1999;44:549–51.
  • 344  Kruppa A, Korge B, Lasch J, et al. Successful treatment of Hailey‐Hailey disease with a scanned carbon dioxide laser. Acta Derm Venereol 2000;80:53–4. Cross Ref link Pubmed link
  • 345  Awadalla F, Rosenbach A. Effective treatment of Hailey‐Hailey disease with a long‐pulsed (5 ms) alexandrite laser. J Cosmet Laser Ther 2011;13:191–2. Pubmed link
  • 346  Pretel‐Irazabal M, Lera‐Imbuluzqueta JM, España‐Alonso A. Carbon dioxide laser treatment in Hailey‐Hailey disease: a series of 8 patients. Actas Dermo‐Sifiliográficas 2013;104:325–33. Cross Ref link Pubmed link
  • 347  Stolze I, Hamm H, Weyandt GH. Segmental multilayered argon plasma coagulation: effective therapy option for perianal and scrotal Hailey‐Hailey disease. Colorectal Dis 2011;13:802–4. Cross Ref link Pubmed link
  • 348  Isbary G, Morfill G, Zimmermann J, et al. Cold atmospheric plasma: a successful treatment of lesions in Hailey‐Hailey disease. Arch Dermatol 2011;147:388–90. Cross Ref link Pubmed link
  • 349  Guérin‐Surville H, Guérin‐Surville L, Lelouarn C, et al. [Surgical treatment of Hailey‐Hailey disease with surgical grafts.] Ann Dermatol Vénéréologie 1984;111:699–700.
  • 350  Guérin‐Surville H, Guérin‐Surville L, Le Louarn C, et al. [Surgical treatment of Hailey‐Hailey disease by surgical grafting (2d report): results after a >5‐year follow‐up.] Ann Dermatol Vénéréologie 1989;116:904–5.
  • 351  Shons AR. Wide excision of perineal Hailey‐Hailey disease with healing by secondary intention. Br J Plast Surg 1989;42:230–2. Cross Ref link Pubmed link
  • 352  Menz P, Jackson IT, Connolly S. Surgical control of Hailey‐Hailey disease. Br J Plast Surg 1987;40:557–61. Cross Ref link Pubmed link
  • 353  Aubert JP, Folchetti G, Berbis P, Magalon G. [Surgical treatment of Hailey‐Hailey disease or benign chronic familial pemphigus. Apropos of a case of submammary localization.] Ann Chir Plast Esthétique 1993;38:568–71.
  • 354  Sarkany I. Grenz‐ray treatment of familial benign chronic pemphigus. Br J Dermatol 1959;71:247–52. Cross Ref link Pubmed link
  • 355  Roos DE, Reid CM. Benign familial pemphigus: little benefit from superficial radiotherapy. Australas J Dermatol 2002;43:305–8. Cross Ref link Pubmed link
  • 356  Narbutt J, Lesiak A, Arkuszewska C, et al. Effective treatment of recalcitrant Hailey‐Hailey disease with electron beam radiotherapy. J Eur Acad Dermatol Venereol 2007;21:567–8. Pubmed link
  • 357  Lapiere JC, Hirsh A, Gordon KB, et al. Botulinum toxin type A for the treatment of axillary Hailey‐Hailey disease. Dermatol Surg 2000;26:371–4. Cross Ref link Pubmed link
  • 358  Kang N‐G, Yoon T‐J, Kim T‐H. Botulinum toxin type A as an effective adjuvant therapy for Hailey‐Hailey disease. Dermatol Surg 2002;28:543. Pubmed link
  • 359  Koeyers WJ, Van Der Geer S, Krekels G. Botulinum toxin type A as an adjuvant treatment modality for extensive Hailey‐Hailey disease. J Dermatol Treat 2008;19:251–4. Cross Ref link
  • 360  Hayakawa K, Shiohara T. Coexistence of psoriasis and familial benign chronic pemphigus: efficacy of ultraviolet B treatment. Br J Dermatol 1999;140:374–5. Cross Ref link Pubmed link
  • 361  Suhonen R, Niemi KM. Ultraviolet light in familial benign chronic pemphigus. J Cutan Pathol 1979;6:414–17. Cross Ref link Pubmed link
  • 362  Ruiz‐Rodriguez R, Alvarez JG, Jaén P, et al. Photodynamic therapy with 5‐aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey‐Hailey disease). J Am Acad Dermatol 2002;47:740–2. Cross Ref link Pubmed link
  • 363  Fernández Guarino M, Ryan AM, Harto A, et al. Experience with photodynamic therapy in Hailey‐Hailey disease. J Dermatol Treat 2008;19:288–90. Cross Ref link